Side-by-side comparison of AI visibility scores, market position, and capabilities
Karachi Pakistan earned wage access platform at $64.1M total ($17M Speedinvest/FJ Labs Series A Apr 2022) serving Pakistani employees and SMEs through United Bank Limited and Bank Alfalah; cash flow positive competing with Wagestream for South Asia EWA.
Abhi is a Karachi, Pakistan-based financial wellness and earned wage access platform — backed with $64.1 million in total funding including a $17 million Series A in April 2022 led by Speedinvest with Global Ventures, VentureSouq, VEF (Vostok Emerging Finance), Sturgeon Capital, Rallycap, and FJ Labs, following a pre-Series A in November 2021 led by Global Ventures and a $2 million seed in 2021 from Vostok Emerging Finance — providing Pakistani employees with on-demand access to accrued salary before payday (earned wage access), expanding into B2B business financing services for SMEs, and partnering with United Bank Limited and Bank Alfalah for distribution across hundreds of corporate clients. Founded in 2019 and achieving cash flow positive operations, Abhi serves the Pakistani workforce with financial tools addressing the liquidity gap between salary payment dates that pushes employees toward informal high-cost borrowing.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.